Switch acceptance and persistence of adalimumab biosimilars in IBD patients: a prospective observational study
Background: Prospective data about the acceptance and outcomes of switching from the adalimumab (ADA) reference product (RP) to multiple ADA biosimilars in inflammatory bowel disease (IBD) patients are lacking. Objectives: To evaluate the acceptance rate of switching from the ADA RP to ADA biosimila...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-04-01
|
| Series: | Therapeutic Advances in Gastroenterology |
| Online Access: | https://doi.org/10.1177/17562848251332025 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|